MAZE
NASDAQ · Pharmaceuticals
Maze Therapeutics Inc
$27.33
+0.41 (+1.52%)
Analyst Consensus
Strong Buy
18
Analysts
High
Coverage
Price Target
Analyst Price Target
+243.6% upside
Low Target
$74.59
Average Target
$93.90
High Target
$145.81
Current Price
$27.33
Current
$27.33
$27.33
Target
$93.90
$93.90
$74.59
$93.90 avg
$145.81
Scenario Analysis
Bear Case
$74.59
172.9%
Low target
Base Case
$93.90
+243.6%
Avg target
Bull Case
$145.81
+433.5%
High target
Risk/Reward
2.5x
Favorable
Price in Context
52-Week High
$53.65
-49.1% from high
52-Week Low
$12.81
+113.3% from low
50-Day SMA
$42.71
-36.0% vs SMA
200-Day SMA
$25.83
+5.8% vs SMA
RSI (14)
50.1
Neutral
Target vs 52W High
$93.90
+75.0% vs high
Next Earnings Report
Aug 18, 2026
9d
until earnings
EPS Est: $-0.75
Earnings in 9 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals